These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 35397361

  • 1. Mutational analysis using next generation sequencing in pediatric thyroid cancer reveals BRAF and fusion oncogenes are common.
    Newfield RS, Jiang W, Sugganth DX, Hantash FM, Lee E, Newbury RO.
    Int J Pediatr Otorhinolaryngol; 2022 Jun; 157():111121. PubMed ID: 35397361
    [Abstract] [Full Text] [Related]

  • 2. Mutational Analysis in Pediatric Thyroid Cancer and Correlations with Age, Ethnicity, and Clinical Presentation.
    Nikita ME, Jiang W, Cheng SM, Hantash FM, McPhaul MJ, Newbury RO, Phillips SA, Reitz RE, Waldman FM, Newfield RS.
    Thyroid; 2016 Feb; 26(2):227-34. PubMed ID: 26649796
    [Abstract] [Full Text] [Related]

  • 3. NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States.
    Prasad ML, Vyas M, Horne MJ, Virk RK, Morotti R, Liu Z, Tallini G, Nikiforova MN, Christison-Lagay ER, Udelsman R, Dinauer CA, Nikiforov YE.
    Cancer; 2016 Apr 01; 122(7):1097-107. PubMed ID: 26784937
    [Abstract] [Full Text] [Related]

  • 4. RET, NTRK, ALK, BRAF, and MET Fusions in a Large Cohort of Pediatric Papillary Thyroid Carcinomas.
    Pekova B, Sykorova V, Dvorakova S, Vaclavikova E, Moravcova J, Katra R, Astl J, Vlcek P, Kodetova D, Vcelak J, Bendlova B.
    Thyroid; 2020 Dec 01; 30(12):1771-1780. PubMed ID: 32495721
    [Abstract] [Full Text] [Related]

  • 5. Concomitant RAS, RET/PTC, or BRAF mutations in advanced stage of papillary thyroid carcinoma.
    Zou M, Baitei EY, Alzahrani AS, BinHumaid FS, Alkhafaji D, Al-Rijjal RA, Meyer BF, Shi Y.
    Thyroid; 2014 Aug 01; 24(8):1256-66. PubMed ID: 24798740
    [Abstract] [Full Text] [Related]

  • 6. PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma.
    Castro P, Rebocho AP, Soares RJ, Magalhães J, Roque L, Trovisco V, Vieira de Castro I, Cardoso-de-Oliveira M, Fonseca E, Soares P, Sobrinho-Simões M.
    J Clin Endocrinol Metab; 2006 Jan 01; 91(1):213-20. PubMed ID: 16219715
    [Abstract] [Full Text] [Related]

  • 7. Fusion Oncogenes Are the Main Genetic Events Found in Sporadic Papillary Thyroid Carcinomas from Children.
    Cordioli MI, Moraes L, Bastos AU, Besson P, Alves MT, Delcelo R, Monte O, Longui C, Cury AN, Cerutti JM.
    Thyroid; 2017 Feb 01; 27(2):182-188. PubMed ID: 27849443
    [Abstract] [Full Text] [Related]

  • 8. Clinical utility of TERT promoter mutations and ALK rearrangement in thyroid cancer patients with a high prevalence of the BRAF V600E mutation.
    Bae JS, Kim Y, Jeon S, Kim SH, Kim TJ, Lee S, Kim MH, Lim DJ, Lee YS, Jung CK.
    Diagn Pathol; 2016 Feb 09; 11():21. PubMed ID: 26857243
    [Abstract] [Full Text] [Related]

  • 9. Oncogenic alterations in papillary thyroid cancers of young patients.
    Sassolas G, Hafdi-Nejjari Z, Ferraro A, Decaussin-Petrucci M, Rousset B, Borson-Chazot F, Borbone E, Berger N, Fusco A.
    Thyroid; 2012 Jan 09; 22(1):17-26. PubMed ID: 22150560
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Pathogenesis of differentiated thyroid cancer (papillary and follicular)].
    Maciel RM, Kimura ET, Cerutti JM.
    Arq Bras Endocrinol Metabol; 2005 Oct 09; 49(5):691-700. PubMed ID: 16444351
    [Abstract] [Full Text] [Related]

  • 12. Integrating Molecular Testing in the Diagnosis and Management of Children with Thyroid Lesions.
    Ballester LY, Sarabia SF, Sayeed H, Patel N, Baalwa J, Athanassaki I, Hernandez JA, Fang E, Quintanilla NM, Roy A, López-Terrada DH.
    Pediatr Dev Pathol; 2016 Oct 09; 19(2):94-100. PubMed ID: 26366474
    [Abstract] [Full Text] [Related]

  • 13. Genetic alterations in the RAS/RAF/mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways in the follicular variant of papillary thyroid carcinoma.
    Santarpia L, Myers JN, Sherman SI, Trimarchi F, Clayman GL, El-Naggar AK.
    Cancer; 2010 Jun 15; 116(12):2974-83. PubMed ID: 20564403
    [Abstract] [Full Text] [Related]

  • 14. Concomitant BRAF(V600E) mutation and RET/PTC rearrangement is a frequent occurrence in papillary thyroid carcinoma.
    Guerra A, Zeppa P, Bifulco M, Vitale M.
    Thyroid; 2014 Feb 15; 24(2):254-9. PubMed ID: 23806056
    [Abstract] [Full Text] [Related]

  • 15. Application value of multi-gene mutation detection in the clinical management of pediatric papillary thyroid carcinoma: a preliminary exploration.
    Wang Y, Wang H, Tan G, Wu X, Wang B, Tan Z, Du J, Li X, Xu Y, Yan N, Qian X.
    Front Endocrinol (Lausanne); 2024 Feb 15; 15():1405142. PubMed ID: 38904052
    [Abstract] [Full Text] [Related]

  • 16. Genetic alterations in thyroid tumors from patients irradiated in childhood for tinea capitis treatment.
    Boaventura P, Pereira D, Celestino R, Mendes A, Nakasawa T, Teixeira-Gomes J, Sobrinho-Simões M, Soares P.
    Eur J Endocrinol; 2013 Nov 15; 169(5):673-9. PubMed ID: 23966419
    [Abstract] [Full Text] [Related]

  • 17. Molecular Testing for Oncogenic Gene Alterations in Pediatric Thyroid Lesions.
    Mostoufi-Moab S, Labourier E, Sullivan L, LiVolsi V, Li Y, Xiao R, Beaudenon-Huibregtse S, Kazahaya K, Adzick NS, Baloch Z, Bauer AJ.
    Thyroid; 2018 Jan 15; 28(1):60-67. PubMed ID: 29108474
    [Abstract] [Full Text] [Related]

  • 18. Genetic alterations of differentiated thyroid carcinoma in iodine-rich and iodine-deficient countries.
    Vuong HG, Kondo T, Oishi N, Nakazawa T, Mochizuki K, Inoue T, Tahara I, Kasai K, Hirokawa M, Tran TM, Katoh R.
    Cancer Med; 2016 Aug 15; 5(8):1883-9. PubMed ID: 27264674
    [Abstract] [Full Text] [Related]

  • 19. Investigation of V600E BRAF mutation in papillary thyroid carcinoma in the Polish population.
    Brzeziańska E, Pastuszak-Lewandoska D, Wojciechowska K, Migdalska-Sek M, Cyniak-Magierska A, Nawrot E, Lewiński A.
    Neuro Endocrinol Lett; 2007 Aug 15; 28(4):351-9. PubMed ID: 17693984
    [Abstract] [Full Text] [Related]

  • 20. Follicular histotypes of oncocytic thyroid carcinomas do not carry mutations of the BRAF hot-spot.
    Musholt PB, Musholt TJ, Morgenstern SC, Worm K, Sheu SY, Schmid KW.
    World J Surg; 2008 May 15; 32(5):722-8. PubMed ID: 18235983
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.